Luke Reid - Microba Life Chief Officer
| MAP Stock | 0.19 0.01 5.56% |
Executive
Luke Reid is Chief Officer of Microba Life Sciences
| Address | 324 Queen Street, Brisbane, QLD, Australia, 4000 |
| Phone | 61 13 0097 4621 |
| Web | https://microba.com |
Microba Life Management Efficiency
The company has return on total asset (ROA) of (0.3076) % which means that it has lost $0.3076 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4998) %, meaning that it generated substantial loss on money invested by shareholders. Microba Life's management efficiency ratios could be used to measure how well Microba Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Microba Life's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 4.7 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 34.4 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| BCom CSP | Infomedia | 58 | |
| Konstanty Bialkowski | EMvision Medical Devices | N/A | |
| Matthew Stanton | Nine Entertainment Co | N/A | |
| Michael Oki | Infomedia | N/A | |
| Maria Phillips | Nine Entertainment Co | N/A | |
| Michael Stephenson | Nine Entertainment Co | N/A | |
| Kurt Burnette | Seven West Media | N/A | |
| Angus Ross | Seven West Media | N/A | |
| Tory Maguire | Nine Entertainment Co | N/A | |
| Robert Cronin | Seven West Media | N/A | |
| Lucinda Gemmell | Seven West Media | N/A | |
| Forough Khandan | EMvision Medical Devices | N/A | |
| Barry Marchini | Ainsworth Game Technology | N/A | |
| Christian Wight | EMvision Medical Devices | N/A | |
| Alex Parsons | Nine Entertainment Co | N/A | |
| Nola Hodgson | Nine Entertainment Co | N/A | |
| Tom Malone | Nine Entertainment Co | N/A | |
| Jeffrey Howard | Seven West Media | N/A | |
| Liana Dubois | Nine Entertainment Co | N/A | |
| BBA BBA | Infomedia | N/A | |
| Gereurd Roberts | Seven West Media | N/A | |
Management Performance
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.31 |
Microba Life Sciences Leadership Team
Elected by the shareholders, the Microba Life's board of directors comprises two types of representatives: Microba Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microba. The board's role is to monitor Microba Life's management team and ensure that shareholders' interests are well served. Microba Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microba Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Wood, Head Operations | ||
| Luke Reid, Chief Officer | ||
| Yao Liu, Chief Officer | ||
| Nicola Angel, Head Operations | ||
| Pr Krause, Chief Officer | ||
| Pr Hugenholtz, CoFounder Board | ||
| Pr Munro, Senior Therapeutics | ||
| Pr Tyson, CoFounder Director | ||
| Kylie Ellis, Head Partnerships | ||
| James Heath, CFO Secretary | ||
| Drew Webb, Chief Officer | ||
| Bernie Woodcroft, Senior Solutions |
Microba Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Microba Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.31 | ||||
| Profit Margin | (1.65) % | ||||
| Operating Margin | (1.31) % | ||||
| Current Valuation | 61.31 M | ||||
| Shares Outstanding | 447.85 M | ||||
| Shares Owned By Insiders | 54.55 % | ||||
| Shares Owned By Institutions | 22.83 % | ||||
| Price To Book | 1.96 X | ||||
| Price To Sales | 6.67 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microba Stock Analysis
When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.